Contact Us

Methylin
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

   * Phone 

Cell Phone 

Date you started taking this drug:

Date you stopped taking this drug:

Did you (or injured party) experience any of the following:





Please describe side effects:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Parker Waichman LLP Headlines by Topic

Methylin

ADHD drugmakers must tell of risks

Feb 23, 2007
| SOUTH FLORIDA SUN-SENTINEL
Federal officials told the makers of Ritalin, Adderall, Strattera and all other drugs for treatment of attention deficit hyperactivity disorder, or...

Government wants further ADHD drug warnings

Feb 22, 2007
| Baltimore Sun
The makers of Ritalin, Adderall, Strattera and other drugs treating attention-deficit hyperactivity disorder were advised by the government Wednesday...

ADHD drug makers to warn of side effects

Feb 21, 2007
| AP
Drugs prescribed to treat attention deficit hyperactivity disorder will include guides to alert patients and parents of the risks of mental and heart...

Drug makers to add warnings to ADHD pills

Feb 21, 2007
| AP
Drugs prescribed to treat attention deficit hyperactivity disorder will include guides to alert patients and parents of the risks of mental and heart...

ADHD Drugs to Get New Warnings

Feb 21, 2007
| NewsInferno.com
The U.S. Food and Drug Administration (FDA) announced today that it is ordering all manufacturers of attention deficit hyperactivity disorder (ADHD)...

FDA orders warning 'guides' for ADHD drugs

Feb 21, 2007
| USA Today
Pharmacists will soon begin handing out consumer-friendly "medication guides" about cardiovascular and psychiatric problems linked to...

FDA Directs ADHD Drug Manufacturers to Notify Patients about Cardiovascular Adverse Events and Psychiatric Adverse Event

Feb 21, 2007
| www.fda.gov
The U.S. Food and Drug Administration (FDA) today directed the manufacturers of all drug products approved for the treatment of Attention Deficit...

ADD Drug Strattera, Already Under FDA Scrutiny, Raising New Safety Concerns in UK as Well

Feb 21, 2006
| Newsinferno News Staff
Although pharmaceutical giant Eli Lilly (Lilly) continues to maintain that its attention deficit drug, Strattera, is safe, the company’s...

Page 1/1